文献速递肝病消化内镜

磁共振弹性成像测肝硬度变化与原发性硬化性胆管炎肝功能失代偿相关

Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-11-01

该回顾性研究纳入204例原发性硬化性胆管炎患者,分析两次磁共振弹性成像(MRE)测定的肝硬度(LS)变化与肝功能失代偿的关系。结果显示,基线LS及LS随时间变化均独立与失代偿相关,失代偿者LS中位年变化为0.60 kPa/y,而未失代偿者保持稳定。

要点

  • 基线LS及LS年变化率均独立与PSC患者肝功能失代偿相关。
  • 失代偿者LS中位年变化为0.60 kPa/y,未失代偿者变化不明显。
  • 无晚期纤维化或失代偿者LS变化缓慢,提示监测频率可个体化。

核心结论

  • 单次LS测量和LS随时间变化均独立与PSC患者肝功能失代偿相关。
  • 无晚期纤维化或肝功能失代偿的患者LS变化缓慢。

研究设计与样本

  • 计算ΔLS/time为第二次与第一次MRE间LS变化除以检查间隔时间。
  • 主要终点为肝功能失代偿(腹水、静脉曲张出血或肝性脑病)。

主要发现

  • 中位LS为2.72 kPa(四分位距2.32-3.44 kPa),总体LS变化为0.05 kPa/y。
  • 预期肝硬化患者ΔLS/y为0.31 kPa/y,是无纤维化患者(0.03 kPa/y)的10倍。
  • 最终发生肝功能失代偿者中位LS变化为0.60 kPa/y(四分位距0.21-1.26 kPa/y),未发生者为减少0.04/y(四分位距减少0.26至0.17 kPa/y),P < .001。
  • 与肝功能失代偿最高风险相关的ΔLS/y为0.34 kPa/y(HR 13.29;95% CI 0.23-33.78)。
  • 与肝功能失代偿相关的最佳单次LS cut-off为4.32 kPa(HR 60.41;95% CI 17.85-204.47)。

关键数值与推荐

  • 调整基线LS、碱性磷酸酶和Mayo PSC风险评分后,ΔLS/y仍与肝功能失代偿相关。
  • 联合ΔLS/y cut-off 0.34 kPa/y和单次LS cut-off 4.32 kPa与肝功能失代偿风险相关(一致性评分0.93;95% CI 0.88-0.98)。

临床怎么用

  • 对PSC患者可结合单次LS和纵向LS变化评估肝功能失代偿风险。
  • 无晚期纤维化或失代偿者LS变化缓慢,可考虑减少监测频率。

局限性

  • 单中心回顾性研究,样本量204例。
  • ΔLS/y cut-off 0.34 kPa/y的HR 95% CI下限为0.23,提示估计不精确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Single measurements of liver stiffness (LS) by magnetic resonance elastography (MRE) have been associated with outcomes of patients with primary sclerosing cholangitis (PSC), but the significance of changes in LS over time are unclear. We investigated associations between changes in LS measurement and progression of PSC. METHODS: We performed a retrospective review of 204 patients with patients who underwent 2 MREs at a single center between January 1, 2007 and December 31, 2018. We collected laboratory data and information on revised Mayo PSC risk and model for end-stage liver disease scores, the PSC risk estimate tool, and levels of aspartate transferase at the time of each MRE. The ΔLS/time was determined by the change in LS between the second MRE compared to the first MRE divided by the time between examinations. The primary endpoint was development of hepatic decompensation (ascites, variceal hemorrhage or hepatic encephalopathy). RESULTS: The median LS measurement was 2.72 kPa (interquartile range, 2.32-3.44 kPa) and the overall change in LS was 0.05 kPa/y. However, ΔLS/y was 10-fold higher in patients anticipated to have cirrhosis (0.31 kPa/y) compared to patients with no fibrosis (0.03 kPa/y). The median LS increased over time in patients who ultimately developed hepatic decompensation (0.60 kPa/y; interquartile range, 0.21-1.26 kPa/y) vs but remained static in patients who did not (reduction of 0.04/y; interquartile range, reductions of 0.26 to 0.17 kPa/y) (P < .001). The ΔLS/y value associated with the highest risk of hepatic decompensation was Δ0.34 kPa/y (hazard ratio [HR], 13.29; 95% CI, 0.23-33.78). After we adjusted for baseline LS and other risk factors, including serum level of alkaline phosphatase and the Mayo PSC risk score, ΔLS/y continued to be associated with hepatic decompensation. The optimal single LS cut-off associated with the hepatic decompensation was 4.32 kPa (HR, 60.41; 95% CI, 17.85-204.47). A combination of both cut-off values was associated with risk of hepatic decompensation (concordance score, 0.93; 95% CI, 0.88-0.98) CONCLUSIONS: A single LS measurement and changes in LS over time are independently associated with hepatic decompensation in patients with PSC. However, changes in LS occur slowly in patients without advanced fibrosis or hepatic decompensation.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Eaton JE, Sen A, Hoodeshenas S, et al. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2019. PMID: 31683058. doi:10.1016/j.cgh.2019.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。